103 related articles for article (PubMed ID: 19947936)
1. Termination of tyrphostin AG1478 application results in different recovery of EGF receptor tyrosine residues 1045 and 1173 phosphorylation in A431 cells.
Kondratov KA; Chernorudskiy AL; Amosova AP; Kornilova ES
Cell Biol Int; 2009 Dec; 34(1):81-7. PubMed ID: 19947936
[TBL] [Abstract][Full Text] [Related]
2. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
Ahmed I; Gesty-Palmer D; Drezner MK; Luttrell LM
Mol Endocrinol; 2003 Aug; 17(8):1607-21. PubMed ID: 12738761
[TBL] [Abstract][Full Text] [Related]
5. The tyrphostin AG1478 augments oridonin-induced A431 cell apoptosis by blockage of JNK MAPK and enhancement of oxidative stress.
Yu Y; Fan SM; Ye YC; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2012 Nov; 46(11):1393-405. PubMed ID: 22881126
[TBL] [Abstract][Full Text] [Related]
6. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
[TBL] [Abstract][Full Text] [Related]
7. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
9. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of tyrphostin AG1478 effect on behavior of internalized EGF receptor at different stages of endocytosis].
Kondratov KA; Chernorudskiĭ AL; Amosova AP; Kornilova ES
Tsitologiia; 2009; 51(6):520-5. PubMed ID: 19637756
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
12. Delta-opioid receptors activate ERK/MAP kinase via integrin-stimulated receptor tyrosine kinases.
Eisinger DA; Ammer H
Cell Signal; 2008 Dec; 20(12):2324-31. PubMed ID: 18804531
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.
Weyergang A; Kaalhus O; Berg K
Photochem Photobiol Sci; 2008 Sep; 7(9):1032-40. PubMed ID: 18754049
[TBL] [Abstract][Full Text] [Related]
14. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
15. Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.
Lee FT; Mountain AJ; Kelly MP; Hall C; Rigopoulos A; Johns TG; Smyth FE; Brechbiel MW; Nice EC; Burgess AW; Scott AM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7080s-7086s. PubMed ID: 16203806
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
18. In brown adipocytes, adrenergically induced β₁-/β₃-(Gs)-, α₂-(Gi)- and α₁-(Gq)-signalling to Erk1/2 activation is not mediated via EGF receptor transactivation.
Wang Y; Fälting JM; Mattsson CL; Holmström TE; Nedergaard J
Exp Cell Res; 2013 Oct; 319(17):2718-27. PubMed ID: 23948306
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
Sneddon WB; Yang Y; Ba J; Harinstein LM; Friedman PA
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1028-34. PubMed ID: 17107942
[TBL] [Abstract][Full Text] [Related]
20. Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell Function.
Kersting N; Kunzler Souza B; Araujo Vieira I; Pereira Dos Santos R; Brufatto Olguins D; José Gregianin L; Tesainer Brunetto A; Lunardi Brunetto A; Roesler R; Brunetto de Farias C; Schwartsmann G
Oncology; 2018; 94(6):383-393. PubMed ID: 29539615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
